Increase in linezolid resistance in staphylococci in the private sector in Western Cape Province, South Africa

To the Editor: Concerns about increasing antimicrobial resistance secondary to the COVID-19 pandemic have been raised previously.[1] We report a marked increase in linezolid resistance in predominantly coagulase-negative staphylococci in the private sector in Western Cape Province, South Africa (SA)...

Full description

Saved in:
Bibliographic Details
Published inSouth African medical journal Vol. 111; no. 11; p. 1031
Main Authors Bamford, C, Senekal, M, Lowman, W
Format Journal Article
LanguageEnglish
Published South Africa Health and Medical Publishing Group (HMPG) 01.11.2021
Health & Medical Publishing Group
Subjects
Anti-Bacterial Agents - pharmacology
Coagulase
Dosage and administration
Drug resistance in microorganisms
Drug Resistance, Bacterial
Drug therapy
Humans
Linezolid
Linezolid - pharmacology
Microbial Sensitivity Tests
South Africa
Staphylococcal infections
Staphylococcal Infections - drug therapy
Staphylococcal Infections - microbiology
Staphylococcus - drug effects
Statistics
South Africa
Online AccessGet full text

Cover

More Information
Summary:To the Editor: Concerns about increasing antimicrobial resistance secondary to the COVID-19 pandemic have been raised previously.[1] We report a marked increase in linezolid resistance in predominantly coagulase-negative staphylococci in the private sector in Western Cape Province, South Africa (SA), in the past 18 months.
ISSN:0256-9574
2078-5135
DOI:10.7196/SAMJ.2021.v111i11.16147